Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision

被引：0
|
作者：
Marisa Donada
Serena Bonin
Renzo Barbazza
Daniel Pettirosso
Giorgio Stanta
机构：
[1] University of Trieste,DSM Department (Department of medical, surgical and health sciences)
[2] Surgical Pathology Bldg,undefined
来源：
BMC Gastroenterology | / 13卷
关键词：
Colon cancer; Stage II; Adjuvant therapy; 5-Fluorouracil; Formalin-fixed and paraffin-embedded tissues; Thymidylate synthase; MMR; CIMP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision
    Donada, Marisa
    Bonin, Serena
    Barbazza, Renzo
    Pettirosso, Daniel
    Stanta, Giorgio
    BMC GASTROENTEROLOGY, 2013, 13
  • [2] Use of Molecular Biomarkers to Inform Adjuvant Therapy for Colon Cancer
    Mettu, Niharika B.
    Hurwitz, Herbert
    Hsu, David S.
    ONCOLOGY-NEW YORK, 2013, 27 (08): : 746 - 754
  • [3] Adjuvant therapy in stage II colon cancer: Current approaches
    Baddi, L
    Benson, A
    ONCOLOGIST, 2005, 10 (05) : 325 - 331
  • [4] Current issues in adjuvant treatment of stage II colon cancer
    Andre, Thierry
    Sargent, Daniel
    Tabernero, Josep
    O'Connell, Michael
    Buyse, Marc
    Sobrero, Alberto
    Misset, Jean-Louis
    Boni, Corrado
    de Gramont, Aimery
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (06) : 887 - 898
  • [5] Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer
    Hagerty, Brendan L.
    Aversa, John G.
    Dominguez, Dana A.
    Davis, Jeremy L.
    Hernandez, Jonathan M.
    McCormick, James T.
    Blakely, Andrew M.
    DISEASES OF THE COLON & RECTUM, 2022, 65 (10) : 1206 - 1214
  • [6] Adjuvant Therapy in Colon Cancer
    Reinacher-Schick, Anke
    Arnold, Dirk
    Trarbach, Tanja
    Ridwelski, Karsten
    Bruch, Hans-Peter
    Kirchner, Thomas
    Kubicka, Stefan
    Schmoll, Hans-Joachim
    ONKOLOGIE, 2010, 33 : 2 - 7
  • [7] Adjuvant therapy for stage II colon cancer: an elephant in the living room?
    Zaniboni, A
    Labianca, R
    ANNALS OF ONCOLOGY, 2004, 15 (09) : 1310 - 1318
  • [8] Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients
    Brenner, Baruch
    Geva, Ravit
    Rothney, Megan
    Beny, Alexander
    Dror, Ygael
    Steiner, Mariana
    Hubert, Ayala
    Idelevich, Efraim
    Gluzman, Alexander
    Purim, Ofer
    Shacham-Shmueli, Einat
    Shulman, Katerina
    Mishaeli, Moshe
    Man, Sophia
    Soussan-Gutman, Lior
    Tezcan, Haluk
    Chao, Calvin
    Shani, Adi
    Liebermann, Nicky
    VALUE IN HEALTH, 2016, 19 (01) : 82 - 87
  • [9] Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: A multicenter randomized phase III study
    Hartung, G
    Hofheinz, RD
    Dencausse, Y
    Sturm, J
    Kopp-Schneider, A
    Dietrich, G
    Fackler-Schwalbe, I
    Bornbusch, D
    Gonnermann, M
    Wojatschek, C
    Lindemann, W
    Eschenburg, H
    Jost, K
    Edler, L
    Hochhaus, A
    Queisser, W
    ONKOLOGIE, 2005, 28 (6-7): : 347 - 350
  • [10] Adjuvant therapy of stage III colon cancer
    Sun, Weijing
    Haller, Daniel G.
    CHINESE CLINICAL ONCOLOGY, 2013, 2 (02)
12345